Summary
Insulin-dependent diabetes develops as a cosequence of the selective destruction of insulin-producing cells by an autoimmune reaction. However, the precise series of events which trigger anti-islet autoreactive T cells is still being investigated. Major issues will need to be raised before a comprehensive view of the anti-islet autoimmune reaction can be delineated. These include defining the primary site of activation of autoreactive lymphocytes and exploring hypotheses to explain the chronicity of the diabetes process. These issues all relate with the more general dilemma of the actual role of the islets of Langerhans in breaking self tolerance to beta-cell antigens. By studying non-obese diabetic mice deprived of beta cells following a single injection of a high dose of alloxan at 3 weeks of age, we recently obtained evidence that the activation of autoreactive T cells requires the presence of target islet cells in order to develop.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- GAD:
-
glutamic acid decarboxylase
- EAE:
-
experimental allergic encephalomyelitis
- NOD:
-
non-obese diabetic
- LCMV:
-
lymphochoriomeningitis virus
- BB:
-
bio-breeding
- TNF:
-
tumour necrosis factor
- CFA:
-
complete Freund's adjuvant
- Poly I:C:
-
Polyinosinic polycitidilic acid
- EMC:
-
encephalomyocarditis
- OS:
-
obese strain
- MHC:
-
major hisocompatibility complex
References
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet II: 1279–1283
Palmer JP, Asplin CM, Clemons P et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Baekkeskov S, Aanstoot HJ, Christgau S et al. (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151–156
Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS (1991) Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab 73: 1197–1201
Boitard C, Villa MC, Becourt C et al. (1992) Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc Natl Acad Sci USA 89: 172–176
Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL (1990) Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 172: 789–794
Pietropaolo M, Castano L, Babu S et al. (1993) Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92: 359–371
Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–143
Huang SW, MacLaren NK (1976) Insulin-dependent diabetes: a disease of autoaggression. Science 192: 64–66
Boitard C, Chatenoud L, Debray-Sachs M (1982) In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon. J Immunol 129: 2529–2531
Harrison LC, de Aizpurua H, Loudovaris T et al. (1991) Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 40: 1128–1133
Van Vliet E, Roep BO, Meulenbroek L, Braining GJ, de Vries RR (1989) Human T cell clones with specificity for insulinoma cell antigens. Eur J Immunol 19: 213–216
Roep BO, Arden SD, de Vries RR, Hutton JC (1990) T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345: 632–634
Roep BO, Kallan AA, Hazenbos WL et al. (1991) T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337: 1439–1441
Atkinson MA, Kaufman DL, Campbell L et al. (1992) Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458–459
Harrison LC, Honeyman MC, de Aizpurua HJ et al. (1993) Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365–1369
Honeyman MC, Cram DS, Harrison LC (1993) Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med 177: 535–540
Lehmann PV, Forsthuber T, Miller A, Sercarz EE (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155–157
Miller BJ, Appel MC, O'Neil JJ, Wicker LS (1988) Both the Lyt-2 + and L3T4 + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140: 52–58
Bendelac A, Carnaud C, Boitard C, Bach JF (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4 + and Lyt-2 + T cells. J Exp Med 166: 823–832
Koevary S, Rossini A, Stoller W, Chick W, Williams RM (1983) Passive transfer of diabetes in the BB/W rat. Science 220: 727–728
Haskins K, Portas M, Bergman B, Lafferty K, Bradley B (1989) Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 86: 8000–8004
Haskins K, McDuffie M (1990) Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249: 1433–1436
Shimizu J, Kanagawa O, Unanue ER (1993) Presentation of beta-cell antigens to CD4 + and CD8 + T cells of nonobese diabetic mice. J Immunol 151: 1723–1730
Nagata M, Yokono K, Hayakawa M et al. (1989) Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J Immunol 143: 1155–1162
Sarvetnick N, Shizuru J, Liggitt D et al. (1990) Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 346: 844–847
Sibley RK, Sutherland DE, Goetz F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53: 132–144
Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360
Young LH, Peterson LB, Wicker LS, Persechini PM, Young JD (1989) In vivo expression of perform by CD8 + lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J Immunol 143: 3994–3999
Laufer TM, Von Herrath MG, Grusby MJ, Oldstone MB, Glimcher LH (1993) Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. J Exp Med 178: 589–596
Bradley BJ, Haskins K, La Rosa FG, Lafferty KJ (1992) CD8 T cells are not required for islet destruction induced by a CD4 + islet-specific T-cell clone. Diabetes 41: 1603–1608
Prowse SJ, Bellgrau D, Lafferty KJ (1986) Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes 35: 110–114
Wang Y, Pontesilli O, Gill RG, La Rosa FG, Lafferty KJ (1991) The role of CD4 + and CD8 + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci USA 88: 527–531
Bendelac A, Boitard C, Bedossa P, Bazin H, Bach JF, Carnaud C (1988) Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 141: 2625–2628
Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232: 1545–1547
Sutton R, Gray DW, McShane P, Dallman MJ, Morris PJ (1989) The specificity of rejection and the absence of susceptibility of pancreatic islet beta cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat. J Exp Med 170: 751–762
Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H (1990) Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 87: 968–972
Satoh J, Seino H, Abo T et al. (1989) Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 84: 1345–1348
Higuchi Y, Herrera P, Muniesa P et al. (1992) Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176: 1719–1731
Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA (1992) Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc Natl Acad Sci USA 89: 10036–10040
Rapoport MJ, Jaramillo A, Zipris D et al. (1993) Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178: 87–99
Boitard C (1992) The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects. Diabetologia 35: 1101–1112
Ohashi PS, Oehen S, Buerki K et al. (1991) Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305–317
Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H (1991) Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65: 319–331
Ghosh S, Palmer SM, Rodrigues NR et al. (1993) Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet 4: 404–409
Van Schravendijk CF, Kiekens R, Pipeleers DG (1992) Pancreatic beta cell heterogeneity in glucose-induced insulin secretion. J Biol Chem 267: 21344–21348
Elliott RB, Reddy SN, Bibby NJ, Kida K (1988) Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia 31: 62–64
Oldstone MB (1990) Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J Exp Med 171: 2077–2089
Oldstone MB, Ahmed R, Salvato M (1990) Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus. J Exp Med 171: 2091–2100
Elliott RB, Martin JM (1984) Dietary protein: a trigger of insulin-dependent diabetes in the BB rat? Diabetologia 26: 297–299
Lefkowith J, Schreiner G, Cormier J et al. (1990) Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes. J Exp Med 171: 729–743
Dyrberg T, Schwimmbeck PL, Oldstone MB (1988) Inhibition of diabetes in BB rats by virus infection. J Clin Invest 81: 928–931
Fox HS (1992) Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 175: 1409–1412
Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M (1991) Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 129: 1382–1390
Sobel DO, Newsome J, Ewel CH et al. (1992) Poly I:C induces development of diabetes mellitus in BB rat. Diabetes 41: 515–520
Guberski DL, Thomas VA, Shek WR et al. (1991) Induction of type I diabetes by Kilham's rat virus in diabetesresistant BB/Wor rats. Science 254: 1010–1013
Thomas VA, Woda BA, Handler ES, Greiner DL, Mordes JP, Rossini AA (1991) Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes 40: 255–258
McDuffie M, Ostrowska A (1993) Superantigen-like effects and incidence of diabetes in NOD mice. Diabetes 42: 1094–1098
Augstein P, Kohnert KD, Ziegler B, Furll B, Heinke P, Ziegler M (1993) Induction of islet cell surface and insulin antibodies in Balb/c mice by application of porcine insulin and Freund's adjuvant is not associated with insulitis. Horm Metab Res 25: 344–347
Elias D, Markovits D, Reshef T, Van Der Zee R, Cohen IR (1990) Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 87: 1576–1580
Onodera T, Ray UR, Melez KA, Suzuki H, Toniolo A, Notkins AL (1982) Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature 297: 66–68
Yoon JW (1991) Role of viruses in the pathogenesis of IDDM. Ann Med 23: 437–445
Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193: 415–417
Kim YT, Steinberg C (1984) Immunologic studies on the induction of diabetes in experimental animals. Cellular basis for the induction of diabetes by streptozotocin. Diabetes 33: 771–777
Paik SG, Fleischer N, Shin SI (1980) Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci USA 77: 6129–6133
Herold KC, Montag AG, Fitch FW (1987) Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin. Diabetes 36: 796–801
Herold KC, Bluestone JA, Montag AG et al. (1992) Prevention of autoimmune diabetes with nonactivating antiCD3 monoclonal antibody. Diabetes 41: 385–391
Cockfield SM, Ramassar V, Urmson J, Halloran PF (1989) Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma. J Immunol 142: 1120–1128
Campbell IL, Oxbrow L, Koulmanda M, Harrison LC (1988) IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol 140: 1111–1116
Herold KC, Montag AG, Buckingham F (1992) Induction of tolerance to autoimmune diabetes with islet antigens. J Exp Med 176: 1107–1114
Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, MacLaren NK, Tobin AJ (1992) Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 89: 283–292
Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551–560
Okamoto M, Murakami M, Shimizu A et al. (1992) A transgenic model of autoimmune hemolytic anemia. J Exp Med 175: 71–79
Tsao BP, Ohnishi K, Cheroutre H et al. (1992) Failed selftolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol 149: 350–358
Strasser A, Whittingham S, Vaux DL et al. (1991) Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88: 8661–8665
Cohen PL, Eisenberg RA (1992) The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today 13: 427–428
Anderson GD, Banerjee S, Luthra HS, David CS (1991) Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice. J Immunol 147: 1189–1193
Heath WR, Allison J, Hoffmann MW et al. (1992) Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359: 547–549
Greiner DL, Handler ES, Nakano K, Mordes JP, Rossini AA (1986) Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol 136: 148–151
Greiner DL, Mordes JP, Handler ES, Angelillo M, Nakamura N, Rossini AA (1987) Depletion of RT6.1 + T lymphocytes induces diabetes in resistant biobreeding/Worcester (BBAV) rats. J Exp Med 166: 461–475
Boitard C, Yasunami R, Dardenne M, Bach JF (1989) T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169: 1669–1680
Formby B, Miller N, Peterson CM (1988) Adoptive immunotherapy of diabetes in autologous nonobese diabetic mice with lymphoid cells ex vivo exposed to cyclosporin plus interleukin 2. Diabetes 37: 1305–1309
McCullagh P (1990) Curtailment of autoimmunity following parabiosis with a normal partner. Immunology 71: 595–597
Fowell D, Mason D (1993) Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4 + T cell subset that inhibits this autoimmune potential. J Exp Med 177: 627–636
Stumbles PA, Penhale WJ (1993) IDDM in rats induced by thymectomy and irradiation. Diabetes 42: 571–578
Zipris D, Lazarus AH, Crow AR, Hadzija M, Delovitch TL (1991) Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. J Immunol 146: 3763–3771
Shehadeh NN, Larosa F, Lafferty KJ (1993) Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6: 291–300
Sempe P, Ezine S, Marvel J et al. (1993) Role of CD4 +CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Int Immunol 5: 479–489
Goldman M, Druet P, Gleichmann E (1991) TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 12: 223–227
Boitard C (1992) B-cell responses in autoimmune diseases. Curr Opin Immunol 4: 741–747
Tan EM (1991) Autoantibodies in pathology and cell biology. Cell 67: 841–842
Teale JM, Sievers KM, Crawley RR, Kotzin BL (1992) Ig V kappa family repertoire of plasma cells derived from autoimmune MRL mice. J Immunol 148: 142–148
Wick G, Brezinschek HP, Hala K, Dietrich H, Wolf H, Kroemer G (1989) The obese strain of chickens: an animal model with spontaneous autoimmune thyroiditis. Adv Immunol 47: 433–500
Brown TR, Sundick RS, Dhar A, Sheth D, Bagchi N (1991) Uptake and metabolism of iodine is crucial for the development of thyroiditis in obese strain chickens. J Clin Invest 88: 106–111
Pontes de Carvalho LC, Templeman J, Wick G, Roitt IM (1982) The role of self-antigen in the development of autoimmunity in obese strain chickens with spontaneous autoallergic thyroiditis. J Exp Med 155: 1255–1266
Atkinson MA, MacLaren NK, Luchetta R (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933–937
Gotfredsen CF, Buschard K, Frandsen EK (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28: 933–935
Gottlieb PA, Handler ES, Appel MC, Greiner DL, Mordes JP, Rossini AA (1991) Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats. Diabetologia 34: 296–300
Thivolet CH, Goillot E, Bedossa P, Durand A, Bonnard M, Orgiazzi J (1991) Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 34: 314–319
Bertrand S, de Paepe M, Vigeant C, Yale JF (1992) Prevention of adoptive transfer in BB rats by prophylactic insulin treatment. Diabetes 41: 1273–1277
Shah SC, Malone JI, Simpson NE (1989) A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 320: 550–554
Keller RJ, Eisenbarth GS, Jackson RA (1993) Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341: 927–928
Helderman JH (1993) The insulin receptor on activated immunocompetent cells. Exp Gerontol 28: 323–327
Bock T, Kjaer TW, Jorgensen M, Josefsen K, Rygaard J, Buschard K (1991) Reduction of diabetes incidence in NOD mice by neonatal glucose treatment. APMIS 99: 989–992
Furuse M, Kimura C, Takahashi H, Okumura J (1991) Prevention of the incidence of diabetes by dietary sorbose in nonobese diabetic mice. J Nutr 121: 1135–1138
Buschard K, Jorgensen M, Aaen K, Bock T, Josefsen K (1990) Prevention of diabetes mellitus in BB rats by neonatal stimulation of beta cells. Lancet 335: 134–135
Adams TE, Alpert S, Hanahan D (1987) Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells. Nature 325: 223–228
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boitard, C., Larger, E., Timsit, J. et al. IDDM: an islet or an immune disease?. Diabetologia 37 (Suppl 2), S90–S98 (1994). https://doi.org/10.1007/BF00400831
Issue Date:
DOI: https://doi.org/10.1007/BF00400831